浅析参麦注射液联合黄芪注射液治疗慢性肺心病临床效果.docVIP

精品论文 参考文献 浅析参麦注射液联合黄芪注射液治疗慢性肺心病临床效果 穆棱市人民医院 157599 摘要： 目的：研究分析参麦注射液联合黄芪注射液治疗慢性肺心病的临床应用价值。方法：此次研究的对象是选择笔者所在医院收治的46例慢性肺心病患者，将其临床资料进行回顾性分析，并随机分为观察组与对照组，对照组23例给予单独的参麦注射液治疗，观察组在对照组基础上给予黄芪注射液治疗。结果：治疗后，观察组患者总有效率为95.65%，对照组患者总有效率为73.91%，两组的总有效率比较差异有统计学意义（Plt;0.05）；两组患者的血气分析值均有所改善，但观察组的改善程度明显优于对照组，差异有统计学意义（Plt;0.01）；两组患者的不良反应比较差异无统计学意义（Pgt;0.05）。结论：参麦注射液联合黄芪注射液治疗慢性肺心病的临床疗效显著，能够从根本上改善心肌功能，无毒副作用，值得在临床上推广。 关键词：参麦注射液；黄芪注射液；慢性肺心病 [Abstract] Objective：To study the clinical application value of Shen Mai injection combined with Astragalus Injection in the treatment of chronic pulmonary heart disease.Methods：the object of the study is choose the hospital treated 46 cases of chronic pulmonary heart disease patients，the clinical data were retrospectively analyzed，and were randomly divided into observation group and control group，control group（23 cases）given alone of Shenmai injection in the treatment，the observation group was treated with Astragalus Injection in the treatment group on the basis of control.Results：after treatment，the patients in the observation group the total efficiency was 95.65%，patients in the control group，the total efficiency was 73.91%，the difference of total efficiency of the two groups had statistical significance（P lt; 0.05）；two groups of patients with value of blood gas analysis were improved，but the observation group improved significantly better than the contrast group，the difference is statistically significant（P lt; 0.01）；comparison of the adverse reactions of two groups of patients with no statistical significance（P gt; 0.05）.Conclusion：Shen Mai injection combined with Astragalus Injection in the treatment of chronic pulmonary heart disease has significant clinical curative effect，can improve cardiac function，no toxic and side effects，it is worth promoting in clinical practice. [Key words] Shen Mai injection；astragalus injection；chronic pulmonary heart disease 慢性肺心病是一种肺源性心脏病，由于肺、胸廓或者肺动脉血管病变引起肺循环阻力增加和肺动脉血压增高，导致右心肥厚、扩大，最终甚至发生右心衰竭。慢性的肺心病是内科临床上